Search results for "MORTALITY"

showing 10 items of 1406 documents

Orthostatic hypotension and health outcomes: an umbrella review of observational studies

2019

To investigate potential relationships between orthostatic hypotension (OH) and negative health outcomes and mortality, through an umbrella review with integrated meta-analyses. Orthostatic hypotension is significantly associated with several negative outcomes in older people, but a suggestive evidence is available only for higher risk of coronary heart disease congestive heart failure, stroke, falls dementia, and all-cause mortality. Orthostatic hypotension seems to be significantly associated with several negative health outcomes in older people, even if only associations with coronary heart disease, congestive heart failure, stroke, falls, dementia, and all-cause mortality are supported …

medicine.medical_specialty030214 geriatricsHeart diseasebusiness.industrymedicine.diseaseLower riskan umbrella review of observational studies- EUROPEAN GERIATRIC MEDICINE cilt.10 ss.863-870 2019 [SOYSAL P. Veronese N. Smith L. Torbahn G. Jackson S. E. Yang L. Ungar A. Rivasi G. Rafanelli M. Petrovic M. et al. -Orthostatic hypotension and health outcomes]03 medical and health sciencesOrthostatic vital signs0302 clinical medicineHeart failureInternal medicineMeta-analysismedicineDementiaObservational study030212 general & internal medicinebusinessStrokeOrthostatic hypotension · Umbrella review · Meta-analysis · Mortality · Fall · Heart failure · Heart disease · Stroke
researchProduct

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia

2020

Abstract Sodium–glucose co-transporter-2 (SGLT2) inhibitors decreased cardiovascular (CV) events and improved renal outcomes in CV safety studies in type 2 diabetes melitus (T2DM) patients at high CV risk. Canagliflozin also improved kidney outcomes in diabetic kidney disease in the Canagliflozin and Renal Events in Diabetes and Nephropathy Clinical Evaluationtrial. More recently, the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) trial showed that dapagliflozin improved CV outcomes in patients with HF with or without diabetes. Protection from HF in non-diabetics was confirmed for empagliflozin in the EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Fa…

medicine.medical_specialty030232 urology & nephrologyUrologyRenal functionType 2 diabetes030204 cardiovascular system & hematologyoutcomesNephropathy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDiabetes mellitusClinical endpointMedicineDapagliflozinAcademicSubjects/MED00340Editorial CommentsCanagliflozinTransplantationclinical trialsbusiness.industrySGLT2 inhibitormedicine.diseasemortalitychemistryNephrologybusinesschronic kidney diseaseKidney diseasemedicine.drugClinical Kidney Journal
researchProduct

The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINEGlobal HealthArticleBetacoronavirusInternal medicinePandemicGlobal healthMedicineHumansMortalityBlood CoagulationPandemicsbiologybusiness.industrySARS-CoV-2AnticoagulantsCOVID-19Thrombosismedicine.diseasebiology.organism_classificationVirologySurvival RatePneumoniaMeta-analysisCardiologyCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsBetacoronavirusThe American journal of cardiology
researchProduct

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

2018

The acute respiratory distress syndrome is a relevant intensive care disease with an incidence ranging between 2.2% and 19% of intensive care unit patients. Despite treatment advances over the last decades, ARDS patients still suffer mortality rates between 35 and 40%. There is still a need for further research to improve the outcome of patients suffering from ARDS. One problem is that no single animal model can mimic the complex pathomechanism of the acute respiratory distress syndrome, but several models exist to study different parts of it. Oleic acid injection (OAI)-induced lung injury is a well-established model for studying ventilation strategies, lung mechanics and ventilation/perfus…

medicine.medical_specialtyARDSSwineGeneral Chemical EngineeringAcute Lung InjuryDiseaseAcute respiratory distressLung injuryGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicinelawIntensive caremedicineAnimalsHumansIntensive care medicineRespiratory Distress SyndromeGeneral Immunology and Microbiologybusiness.industryGeneral NeuroscienceMortality rate030208 emergency & critical care medicinemedicine.diseaseRespiration ArtificialIntensive care unitRespiratory Function TestsDisease Models Animal030228 respiratory systemBreathingMedicinebusinessOleic AcidJournal of Visualized Experiments
researchProduct

Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE st…

2021

Background: Progressive familial intrahepatic cholestasis (PFIC) is an ultra-rare disease with a considerable burden on pediatric patients and their caregivers, impacting quality of life (QoL). The mortality rates highlight a significant need for efficacious treatments. Real-world data on associated costs and QoL are needed to gauge the potential impact of new pharmacological treatments. Methods: Clinical and socio-economic burden of PFIC on patients/caregivers, health systems, and society will be assessed. Patient/caregiver- and physician-level retrospective cross-sectional data will be collected from the US, UK, France, and Germany, for PFIC types 1, 2, 3. A representative sample of physi…

medicine.medical_specialtyATP Binding Cassette Transporter Subfamily BCaregiver BurdenDiseaseCholestasis Intrahepatic03 medical and health sciences0302 clinical medicineQuality of lifeCost of IllnessSurveys and QuestionnairesMedicineHumansPharmacology (medical)030212 general & internal medicineCase report formDisease burdenHealth policyRetrospective Studiesbusiness.industry030503 health policy & servicesHealth PolicyMortality rateProgressive familial intrahepatic cholestasisHealth technologyGeneral Medicinemedicine.diseaseCross-Sectional StudiesSocioeconomic FactorsFamily medicineQuality of Life0305 other medical sciencebusinessDelivery of Health Care
researchProduct

Walking Ability and All-Cause Mortality in Older Women

2010

In this study self-reported ability to walk 2 km and six-minute walking test (6MWT) performance were examined as predictors of all-cause mortality in 434 women, aged 63-76 years. The primary outcome measure was all-cause mortality (follow-up: 8 years). Predictors were self-reported difficulties in walking 2 km and 6-min walking distance tertiles of ≤495, 496-560 and ≥561 m, and no test result due to refusal by the physician to grant permission to perform the test or participant's inability or unwillingness to perform the test. During the follow-up, 39 participants died. Participants reporting minor (age- and body mass index-adjusted hazard ratio 2.53, 95% confidence interval 1.12-5.69) or m…

medicine.medical_specialtyActivities of daily livingmedia_common.quotation_subjectPhysical Therapy Sports Therapy and RehabilitationWalkingRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsActivities of Daily LivingConfidence IntervalsDiseases in TwinsmedicineHealth Status IndicatorsHumansOrthopedics and Sports Medicine030212 general & internal medicineMortalityFinlandAgedmedia_commonExercise Tolerancebusiness.industryHazard ratioConfoundingCardiorespiratory fitnessMiddle AgedConfidence intervalTest (assessment)Chronic DiseaseExercise TestPhysical therapyWomen's HealthFemaleAptitudeSelf ReportRisk assessmentbusinesshuman activities030217 neurology & neurosurgeryInternational Journal of Sports Medicine
researchProduct

Iron deficiency and long-term mortality in elderly patients with acute coronary syndrome.

2018

Aim: We evaluated the relationship between iron deficiency (ID) and long-term mortality risk in elderly patients with acute coronary syndrome (ACS). Methods: In this prospective observational study, we included 252 patients older than 65 years with ACS. Transferrin saturation (TSAT) and ferritin were collected before discharge. Results: Mean age, hemoglobin and GRACE score were 78 ± 7 years, 12.4 ± 1.8 g/dl and 138.8 ± 25.3, respectively, 112(44.4%) patients were women, and 151(59.9%) presented ID. During the follow-up, 121 (48%) patients died. Mortality rates among TSAT quartiles were: 2.38, 1.60, 0.90 and 0.95 × 10 person-years for Q1TSAT to Q4TSAT, respectively (p < 0.001) and did no…

medicine.medical_specialtyAcute coronary syndromeClinical Biochemistry030204 cardiovascular system & hematologyGastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoverymedicineHumans030212 general & internal medicineProspective StudiesAcute Coronary SyndromeAgedAged 80 and overbiologyTransferrin saturationbusiness.industryMortality rateBiochemistry (medical)TransferrinIron deficiencyIron Deficienciesmedicine.diseaseFerritinSurvival RateQuartileFerritinsbiology.proteinObservational studyHemoglobinbusinessBiomarkers in medicine
researchProduct

Predicting mortality with cardiac troponins: recent insights from meta-analyses.

2019

Abstract The introduction of cardiac troponin (cTn) testing in clinical practice has been one of the most important breakthroughs that have occurred in the recent history of laboratory medicine. Although it is now uncontestable that cTn values are essential for diagnosing acute coronary syndrome (ACS), solid evidence is also emerging that assessment of either cardiac troponin I (cTnI) or T (cTnT) may provide valuable prognostic information in the general healthy population, as well as in patients with a vast array of cardiac and extra-cardiac diseases. We have hence performed a critical review of the scientific literature for identifying meta-analyses which have investigated the potential c…

medicine.medical_specialtyAcute coronary syndromeClinical BiochemistryPopulationMedicine (miscellaneous)Disease030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicinedeath; mortality; prediction; troponinTroponin complexMeta-Analysis as TopicTroponin TInternal medicinedeathTroponin ImedicineHumans030212 general & internal medicineAcute Coronary Syndromeeducationeducation.field_of_studybiologybusiness.industrytroponinHealth PolicyBiochemistry (medical)Troponin IPublic Health Environmental and Occupational Healthpredictionmedicine.diseasePrognosisTroponinmortalityHeart failurebiology.proteinCardiologybusinessDiagnosis (Berlin, Germany)References
researchProduct

0326: Prognostic factors and impact of blood pressure level during the first 48 hours after myocardial infarction

2016

Background High blood pressure and low blood pressure are perfectly identified cardio-vascular risk factors, especially in primary prevention. However, their respective role after myocardial infarction is uncertain, with few data available. Objectives To compare cardio-vascular deaths and events after myocardial infarction between the different blood pressure levels observed during the first forty-eight hours. Methods We carried out an observational, prospective, monocentric study, including all consecutive patients admitted in Dijon’s Cardiologic Intensive Care Unit for myocardial infarction, between February 2012 and February 2014. Systolic blood pressure (SBP) was defined as the average …

medicine.medical_specialtyAcute coronary syndromeEjection fractionbusiness.industryBlood pressure level[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemPrognostic factorsmedicine.diseaseIntensive care unitlaw.inventionSurgeryMyocardial infarctionBlood pressurelawInternal medicineCardiologyMedicineObservational studycardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicinebusinessComputingMilieux_MISCELLANEOUSCardiovascular mortalityArchives of Cardiovascular Diseases Supplements
researchProduct

Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome

2021

Ischemic heart disease (IHD) persists as the leading cause of death in the Western world. In recent decades, great headway has been made in reducing mortality due to IHD, based around secondary prevention. The advent of coronary revascularization techniques, first coronary artery bypass grafting (CABG) surgery in the 1960s and then percutaneous coronary intervention (PCI) in the 1970s, has represented one of the major breakthroughs in medicine during the last century. The benefit provided by these techniques, especially PCI, has been crucial in lowering mortality rates in acute coronary syndrome (ACS). However, in the setting where IHD is most prevalent, namely chronic coronary syndrome (CC…

medicine.medical_specialtyAcute coronary syndromeIschemic heart diseasemedicine.medical_treatmentstress cardiac magnetic resonancelcsh:MedicineChronic coronary syndromeReviewischemiaDisease030204 cardiovascular system & hematologyRevascularizationCoronary artery diseaseCoronary artery disease03 medical and health sciences0302 clinical medicineIschemiaInternal medicineMedicine030212 general & internal medicineCause of deathStress cardiac magnetic resonancechronic coronary syndromebusiness.industryMortality ratelcsh:RPercutaneous coronary interventionGeneral Medicinemedicine.diseaseischemic heart diseaseMyocardial revascularizationmyocardial revascularizationConventional PCICardiologybusinesscoronary artery diseaseJournal of Clinical Medicine
researchProduct